Mikhail Olferiev

554 total citations
11 papers, 388 citations indexed

About

Mikhail Olferiev is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mikhail Olferiev has authored 11 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 9 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mikhail Olferiev's work include Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (4 papers). Mikhail Olferiev is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (4 papers). Mikhail Olferiev collaborates with scholars based in United States. Mikhail Olferiev's co-authors include Mary K. Crow, Kyriakos A. Kirou, Luminita Pricop, Yi Liu, Yogita Ghodke‐Puranik, Emi Masuda, Shizuko Tanaka, Marissa C. Blank, Leila Khalili and Augustine M.K. Choi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Reviews Rheumatology.

In The Last Decade

Mikhail Olferiev

11 papers receiving 380 citations

Peers

Mikhail Olferiev
Maria J H Boumans Netherlands
Jessica M. Dorschner United States
Hanane El Bannoudi United States
Dao X. Nguyen United Kingdom
Sarah L. Rowland United States
Gábor Hutás United States
Mikhail Olferiev
Citations per year, relative to Mikhail Olferiev Mikhail Olferiev (= 1×) peers Niklas Hagberg

Countries citing papers authored by Mikhail Olferiev

Since Specialization
Citations

This map shows the geographic impact of Mikhail Olferiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Olferiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Olferiev more than expected).

Fields of papers citing papers by Mikhail Olferiev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Olferiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Olferiev. The network helps show where Mikhail Olferiev may publish in the future.

Co-authorship network of co-authors of Mikhail Olferiev

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Olferiev. A scholar is included among the top collaborators of Mikhail Olferiev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Olferiev. Mikhail Olferiev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ghodke‐Puranik, Yogita, Mikhail Olferiev, & Mary K. Crow. (2024). Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy. Nature Reviews Rheumatology. 20(10). 635–648. 15 indexed citations
2.
Crow, Mary K., Mikhail Olferiev, & Kyriakos A. Kirou. (2024). Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment. Arthritis & Rheumatology. 76(7). 1002–1012. 4 indexed citations
3.
Olferiev, Mikhail, et al.. (2022). 2104 Lupus autoantibodies associated with cell cycle gene expression in peripheral blood of SLE patients. SHILAP Revista de lepidopterología. A110–A111. 2 indexed citations
4.
Crow, Mary K., Mikhail Olferiev, & Kyriakos A. Kirou. (2018). Type I Interferons in Autoimmune Disease. Annual Review of Pathology Mechanisms of Disease. 14(1). 369–393. 200 indexed citations
5.
Fernández, David, Maria Pabón, Mikhail Olferiev, et al.. (2016). II-19 Elevated plasma cell-free mitochondrial DNA defines a subgroup of lupus patients with membranous lupus nephritis. Innate Immunity. A25.1–A25. 2 indexed citations
6.
Olferiev, Mikhail, et al.. (2016). Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus. Clinical Immunology. 172. 34–43. 18 indexed citations
7.
Crow, Mary K., Mikhail Olferiev, & Kyriakos A. Kirou. (2015). Identification of Candidate Predictors of Lupus Flare.. PubMed. 126. 184–96. 3 indexed citations
8.
Olferiev, Mikhail, et al.. (2014). Measuring Interferon Alpha and Other Cytokines in SLE. Methods in molecular biology. 1134. 131–150. 4 indexed citations
9.
Crow, Mary K., Mikhail Olferiev, & Kyriakos A. Kirou. (2014). Targeting of type I interferon in systemic autoimmune diseases. Translational research. 165(2). 296–305. 89 indexed citations
10.
Olferiev, Mikhail, Emi Masuda, Shizuko Tanaka, Marissa C. Blank, & Luminita Pricop. (2006). The Role of Activating Protein 1 in the Transcriptional Regulation of the Human FCGR2B Promoter Mediated by the -343 G → C Polymorphism Associated with Systemic Lupus Erythematosus. Journal of Biological Chemistry. 282(3). 1738–1746. 22 indexed citations
11.
Olferiev, Mikhail, et al.. (2004). Inhibitory Fc Gamma Receptors: From Gene to Disease. Journal of Clinical Immunology. 24(4). 315–326. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026